56P The prognostic role of KRAS mutations in patients with early-stage lung adenocarcinoma after robotic lobectomy and systematic lymphadenectomy

F.T Gallina,D Marinelli,D Forcella,R Tajè,S Ceddia,F Fusco,E Melis,S Buglioni,P Visca,F Cappuzzo,F Facciolo

doi:10.1016/j.annonc.2022.09.057

56P The prognostic role of KRAS mutations in patients with early-stage lung adenocarcinoma after robotic lobectomy and systematic lymphadenectomy

F.T Gallina, D Marinelli + Show 9 more

Open Access

https://doi.org/10.1016/j.annonc.2022.09.057

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Oct 1, 2022
License type: publisher-specific-oa

Affiliation: Policlinico Umberto I, Sapienza University of Rome, Istituti di Ricovero e Cura a Carattere Scientifico, Fondazione IRCCS Istituto Nazionale dei Tumori

#Prognostic Role Of KRAS Mutations #Systematic Lymphadenectomy + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

KRAS in one of the most frequently altered oncogenes in NSCLC. The prognostic role of the KRAS mutations in early-stage NSCLC is still unclear. In this study we aim to analyze the overall survival (OS) and the disease free survival (DFS) of patients with early stage NSCLC underwent lobectomy and systematic lymphadenectomy.

Full Text